PSNL insider transaction filings
Personalis, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-15. Screen PSNL transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings by 3 insiders — 356,233 shares, $5,083,236 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 100,000 shares @ $15.15 ($1,515,000) by Chen Richard, filed 2026-07-15.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Hall Christopher M — Chief Executive Officer, Director | 2 | — | 2 legs · 200,000 sh · $2,823,000 | 5 |
| Chen Richard — President and CMO | 1 | — | 1 leg · 100,000 sh · $1,515,000 | 2 |
| Tachibana Aaron — CFO AND COO | 2 | — | 2 legs · 56,233 sh · $745,236 | 6 |
Recent Form 4 filings — Personalis, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | Chen Richard — President and CMO | Option exercise (M): 100,000 @ $2.44 · Sale (S): 100,000 @ $15.15 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | Hall Christopher M — Chief Executive Officer, Director | Option exercise (M): 100,000 @ $1.61 · Sale (S): 100,000 @ $15.08 · Option exercise (M): 66,667 (derivative) @ $0 · Option exercise (M): 33,333 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 4,982 @ $5.32 · Sale (S): 4,982 @ $14 · Option exercise (M): 4,982 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Hall Christopher M — Chief Executive Officer, Director | Option exercise (M): 100,000 @ $1.61 · Sale (S): 100,000 @ $13.15 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 28,832 @ $9.16 · Option exercise (M): 22,419 @ $5.32 · Sale (S): 51,251 @ $13.18 · Option exercise (M): 28,832 (derivative) @ $0 · Option exercise (M): 22,419 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4/A | EASTHAM KARIN — Director | Grant/award (A): 6,250 @ $0 | EDGAR |
| 2026-06-05 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 40,000 @ $9.16 · Sale (S): 40,000 @ $12.01 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Hall Christopher M — Chief Executive Officer, Director | Option exercise (M): 19,909 @ $1.61 · Sale (S): 19,909 @ $11.02 · Option exercise (M): 80,091 @ $1.61 · Sale (S): 80,091 @ $11.02 · Option exercise (M): 19,909 (derivative) @ $0 · Option exercise (M): 80,091 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 38,799 @ $9.16 · Sale (S): 38,799 @ $11.58 · Option exercise (M): 38,799 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Bloom Olivia Kyusuk — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Shoff Lonnie — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | MYERS WOODROW A JR — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | EASTHAM KARIN — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | WIDDER KENNETH J — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | BOWMAN A BLAINE — Director | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Grant/award (A): 28,125 @ $0 · Grant/award (A): 168,750 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Chen Richard — President and CMO | Grant/award (A): 46,875 @ $0 · Grant/award (A): 281,250 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Hall Christopher M — Chief Executive Officer, Director | Grant/award (A): 87,500 @ $0 · Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Tachibana Aaron — CFO AND COO | Grant/award (A): 34,375 @ $0 · Grant/award (A): 206,250 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Grant/award (A): 8,333 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Hall Christopher M — PRESIDENT AND CEO, Director | Grant/award (A): 33,333 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Tachibana Aaron — CFO AND COO | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Tempus AI, Inc. — 10% owner | Purchase (P): 64,750 @ $7.67 · Purchase (P): 30,645 @ $8.12 · Purchase (P): 28,827 @ $8.63 · Purchase (P): 9,900 @ $8.84 · Purchase (P): 16,599 @ $9.74 · Purchase (P): 25,225 @ $9.87 · +6 more | EDGAR |
| 2026-01-23 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 1,201 @ $9.16 · Sale (S): 1,201 @ $11.50 · Option exercise (M): 1,201 (derivative) @ $0 | EDGAR |
| 2025-11-28 | 4 | Tachibana Aaron — CFO AND COO | Option exercise (M): 103,668 @ $9.16 · Sale (S): 103,668 @ $10.78 · Option exercise (M): 103,668 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Hall Christopher M — PRESIDENT AND CEO, Director | Sale (S): 29,612 @ $8.99 | EDGAR |
| 2025-07-30 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Sale (S): 452 @ $6.57 | EDGAR |
| 2025-07-30 | 4 | Tachibana Aaron — CFO AND COO | Sale (S): 641 @ $6.57 | EDGAR |
| 2025-05-20 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Sale (S): 1,675 @ $4.95 | EDGAR |
| 2025-05-20 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Sale (S): 910 @ $4.95 | EDGAR |
| 2025-05-20 | 4 | Bloom Olivia Kyusuk — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Shoff Lonnie — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Tachibana Aaron — CFO AND COO | Sale (S): 1,291 @ $4.95 | EDGAR |
| 2025-05-20 | 4 | MYERS WOODROW A JR — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | EASTHAM KARIN — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | WIDDER KENNETH J — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | BOWMAN A BLAINE — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Hall Christopher M — PRESIDENT AND CEO, Director | Grant/award (A): 680,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Tachibana Aaron — CFO AND COO | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Sale (S): 519 @ $5.79 | EDGAR |
| 2025-01-30 | 4 | Tachibana Aaron — CFO AND COO | Sale (S): 708 @ $5.79 | EDGAR |
| 2024-12-18 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Sale (S): 4,834 @ $3.82 | EDGAR |
| 2024-12-18 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Sale (S): 1,513 @ $3.82 | EDGAR |
| 2024-12-18 | 4 | Tachibana Aaron — CFO AND COO | Sale (S): 6,865 @ $3.82 | EDGAR |
| 2024-11-20 | 4 | Moore Stephen Michael — SVP and Chief Legal Officer | Sale (S): 1,693 @ $3.79 | EDGAR |
| 2024-11-20 | 4 | Chen Richard — CHIEF MEDICAL OFFICER AND EVP | Sale (S): 921 @ $3.79 | EDGAR |
| 2024-11-20 | 4 | Tachibana Aaron — CFO AND COO | Sale (S): 1,307 @ $3.79 | EDGAR |
Recent 8-K events — Personalis, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-13 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PSNL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →